Drug Displays Potential in Treating Lung Symptoms of Systemic Sclerosis
Myriams-Fotos / Pixabay

Drug Displays Potential in Treating Lung Symptoms of Systemic Sclerosis

According to a story from Boehringer Ingelheim Pharmaceuticals, Inc., the company has recently announced positive results from a phase 3 clinical trial testing the company's drug nintedanib (marketed as Ofev)…

Continue Reading Drug Displays Potential in Treating Lung Symptoms of Systemic Sclerosis

The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment

The Cure Rare Disease Foundation The Cure Rare Disease Foundation's mission is to increase collaborative efforts between researchers in order to accelerate the development of customized therapies for individuals living with…

Continue Reading The Cure Rare Disease Foundation is Trying to Change the “One Size Fits All” Approach Toward Treatment
Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says
sasint / Pixabay

Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says

According to a story from Science Daily, a review of studies focused on allogeneic stem cell transplants as a treatment for non-Hodgkin lymphoma found that it wasn't possible to conclude…

Continue Reading Utility of Allogeneic Stem Cell Transplant in Non-Hodgkin Lymphoma Unclear, Report Says

First Ever Gene Therapy for Spinal Muscular Atrophy Approved by the FDA

According to a story from PR Newswire, the Novartis company AveXis recently announced that the US Food and Drug Administration (FDA) has approved Zolgensma, making it the first ever gene…

Continue Reading First Ever Gene Therapy for Spinal Muscular Atrophy Approved by the FDA

An In-Depth Discussion About FDA Oversight of Diagnostic Tests and the Effect of Inaccurate Tests on Patients

  Newly diagnosed patients may decide to either receive medical treatment or forego treatment based on the results of their diagnostic test.  As recently reported in PEW, although it is…

Continue Reading An In-Depth Discussion About FDA Oversight of Diagnostic Tests and the Effect of Inaccurate Tests on Patients

A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered

Claudia Stäubert and her team of researchers at the University of Leipzig have just reported noteworthy findings which could impact the future treatment of inflammatory diseases. Lactic acid bacteria, or…

Continue Reading A New Potential Drug Target for Inflammatory Diseases such as Ulcerative Colitis Discovered
Close Menu